Based on the Inventiva Sa stock forecast from 4 analysts, the average analyst target price for Inventiva Sa is USD 11.20 over the next 12 months. Inventiva Sa’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Inventiva Sa is Bearish, which is based on 2 positive signals and 6 negative signals. At the last closing, Inventiva Sa’s stock price was USD 2.85. Inventiva Sa’s stock price has changed by -9.24% over the past week, +13.55% over the past month and -34.63% over the last year.
No recent analyst target price found for Inventiva Sa
No recent average analyst rating found for Inventiva Sa
Company Overview Inventiva Sa
Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH) and other diseases. Its lead product candidate is Lanifibranor, which is in Phase III clinical trial to treat NASH. The company also develops Odiparcil for the treatment of patients with mucopolysaccharidoses type VI. In addition, it has a pipeline of earlier stage programs in oncology and other diseases. The company was founded in 2011 and is headquartered in Daix, France. Read Less
Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH) and other diseases. Its lead product candidate is Lanifibranor, which is in Phase III clinical trial t...Read More
Frequently Asked Questions About Inventiva Sa (IVA) Stock
Based on ratings from 4 analysts Inventiva Sa's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bearish. The stock has 4 buy, sell and 1 hold ratings.
Unfortunately we do not have enough data on IVA's stock to indicate if its a good dividend stock.
Based on targets from 4 analysts, the average taret price for IVA is USD 11.20 over the next 12 months. The maximum analyst target price is USD 17 while the minimum anlayst target price is USD 3.
Unfortunately we do not have enough data on IVA's stock to indicate if its overvalued.
The last closing price of IVA's stock was USD 2.85.
The most recent market capitalization for IVA is USD 0.23B.
Based on targets from 4 analysts, the average taret price for IVA is projected at USD 11.20 over the next 12 months.
This means that IVA's stock price may go up by +292.98% over the next 12 months.
We can't find any ETFs which contains Inventiva Sa's stock.
As per our most recent records Inventiva Sa has 123 Employees.
Inventiva Sa's registered address is 50 rue de Dijon, Daix, France, 21121.
You can get more information about it from Inventiva Sa's website at https://www.inventivapharma.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
High Gross Profit to Asset Ratio
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Frequently Asked Questions About Inventiva Sa (IVA) Stock
Based on ratings from 4 analysts Inventiva Sa's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bearish. The stock has 4 buy, sell and 1 hold ratings.
Unfortunately we do not have enough data on IVA's stock to indicate if its a good dividend stock.
Based on targets from 4 analysts, the average taret price for IVA is USD 11.20 over the next 12 months. The maximum analyst target price is USD 17 while the minimum anlayst target price is USD 3.
Unfortunately we do not have enough data on IVA's stock to indicate if its overvalued.
The last closing price of IVA's stock was USD 2.85.
The most recent market capitalization for IVA is USD 0.23B.
Based on targets from 4 analysts, the average taret price for IVA is projected at USD 11.20 over the next 12 months.
This means that IVA's stock price may go up by +292.98% over the next 12 months.
We can't find any ETFs which contains Inventiva Sa's stock.
As per our most recent records Inventiva Sa has 123 Employees.
Inventiva Sa's registered address is 50 rue de Dijon, Daix, France, 21121.
You can get more information about it from Inventiva Sa's website at https://www.inventivapharma.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for IVA !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
